Status:
UNKNOWN
Prophylaxis of Venous Thromboembolism After Bariatric Surgery
Lead Sponsor:
Rijnstate Hospital
Conditions:
Morbid Obesity
Thromboembolism
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This study is a prospective evaluation of the relationship between lean body weight and anti-Xa activity and 5700 International Units (IU) nadroparin 4 hours after subcutaneous administration in morbi...
Detailed Description
There is no guideline for postoperative thromboembolic prevention in morbidly obese patients. The investigators goal is to examine which dose of nadroparin is effective.
Eligibility Criteria
Inclusion
- Approval for Roux-en-Y gastric bypass
- Total body weight \> 140 kg
Exclusion
- Renal impairment (GFR \< 30ml/min and/ or serum creatinin \> 150 micromol/ml)
- Coagulation disorders
- Use of vitamin K antagonists (such as acenocoumarol) pregnancy
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02295150
Start Date
March 1 2013
End Date
June 1 2015
Last Update
November 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rijnstate Hospital
Arnhem, Wagnerlaan 55, Netherlands, 6800 TA